Instituto Universitario de Tecnologías Biomédicas
Instituto de investigación
Eli Lilly and Company
Indianapolis, EE. UU.Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (4)
2012
-
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy, Vol. 8, Núm. 4, pp. 445-544
2009
-
Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding
Journal of Virology, Vol. 83, Núm. 1, pp. 117-127
2006
-
The hypothalamus-pituitary-ovarian axis as a model system for the study of SERM effects: An overview of experimental and clinical studies
Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs (Springer Berlin Heidelberg), pp. 103-139
2003
-
Effect of treatment with the selective oestrogen receptor modulator LY117018-HCl on pituitary sensitivity to GnRH and subsequent ovulation
Reproduction, Vol. 125, Núm. 4, pp. 597-606